These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 30199576)

  • 1. A Long Noncoding RNA Regulates Hepatitis C Virus Infection Through Interferon Alpha-Inducible Protein 6.
    Liu X; Duan X; Holmes JA; Li W; Lee SH; Tu Z; Zhu C; Salloum S; Lidofsky A; Schaefer EA; Cai D; Li S; Wang H; Huang Y; Zhao Y; Yu ML; Xu Z; Chen L; Hong J; Lin W; Chung RT
    Hepatology; 2019 Mar; 69(3):1004-1019. PubMed ID: 30199576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA 130a Regulates both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic Pathway.
    Duan X; Li S; Holmes JA; Tu Z; Li Y; Cai D; Liu X; Li W; Yang C; Jiao B; Schaefer EA; Fusco DN; Salloum S; Chen L; Lin W; Chung RT
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Noncoding RNA ITPRIP-1 Positively Regulates the Innate Immune Response through Promotion of Oligomerization and Activation of MDA5.
    Xie Q; Chen S; Tian R; Huang X; Deng R; Xue B; Qin Y; Xu Y; Wang J; Guo M; Chen J; Tang S; Li G; Zhu H
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29899107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spliceosome factor SART1 exerts its anti-HCV action through mRNA splicing.
    Lin W; Zhu C; Hong J; Zhao L; Jilg N; Fusco DN; Schaefer EA; Brisac C; Liu X; Peng LF; Xu Q; Chung RT
    J Hepatol; 2015 May; 62(5):1024-32. PubMed ID: 25481564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C Virus Evades Interferon Signaling by Suppressing Long Noncoding RNA Linc-Pint Involving C/EBP-β.
    Khatun M; Zhang J; Ray R; Ray RB
    J Virol; 2021 Aug; 95(17):e0095221. PubMed ID: 34160260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ISG12a inhibits HCV replication and potentiates the anti-HCV activity of IFN-α through activation of the Jak/STAT signaling pathway independent of autophagy and apoptosis.
    Chen Y; Jiao B; Yao M; Shi X; Zheng Z; Li S; Chen L
    Virus Res; 2017 Jan; 227():231-239. PubMed ID: 27777077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
    Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MxA is a positive regulator of type I IFN signaling in HCV infection.
    Shi X; Jiao B; Chen Y; Li S; Chen L
    J Med Virol; 2017 Dec; 89(12):2173-2180. PubMed ID: 28561372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
    Liu B; Chen S; Guan Y; Chen L
    PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-Jun N terminal kinase activation independent from the interferon pathway.
    Rau SJ; Hildt E; Himmelsbach K; Thimme R; Wakita T; Blum HE; Fischer R
    Hepatology; 2013 Jan; 57(1):23-36. PubMed ID: 22814930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-α inducible protein 6 impairs EGFR activation by CD81 and inhibits hepatitis C virus infection.
    Meyer K; Kwon YC; Liu S; Hagedorn CH; Ray RB; Ray R
    Sci Rep; 2015 Mar; 5():9012. PubMed ID: 25757571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA #32 contributes to antiviral responses by controlling interferon-stimulated gene expression.
    Nishitsuji H; Ujino S; Yoshio S; Sugiyama M; Mizokami M; Kanto T; Shimotohno K
    Proc Natl Acad Sci U S A; 2016 Sep; 113(37):10388-93. PubMed ID: 27582466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microrna-130a Downregulates HCV Replication through an atg5-Dependent Autophagy Pathway.
    Duan X; Liu X; Li W; Holmes JA; Kruger AJ; Yang C; Li Y; Xu M; Ye H; Li S; Liao X; Sheng Q; Chen D; Shao T; Cheng Z; Kaj B; Schaefer EA; Li S; Chen L; Lin W; Chung RT
    Cells; 2019 Apr; 8(4):. PubMed ID: 30974864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
    Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
    Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes.
    Wang YZ; Li JL; Wang X; Zhang T; Ho WZ
    World J Gastroenterol; 2017 Aug; 23(32):5895-5903. PubMed ID: 28932081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional innate immunity restricts Hepatitis C Virus infection in induced pluripotent stem cell-derived hepatocytes.
    Schöbel A; Rösch K; Herker E
    Sci Rep; 2018 Mar; 8(1):3893. PubMed ID: 29497123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.
    Mukherjee A; Di Bisceglie AM; Ray RB
    J Virol; 2015 Mar; 89(6):3356-65. PubMed ID: 25589644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
    Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
    Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient virus assembly, but not infectivity, determines the magnitude of hepatitis C virus-induced interferon alpha responses of plasmacytoid dendritic cells.
    Grabski E; Wappler I; Pfaender S; Steinmann E; Haid S; Dzionek A; Pietschmann T; Kalinke U
    J Virol; 2015 Mar; 89(6):3200-8. PubMed ID: 25552725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.
    Zhu C; Xiao F; Hong J; Wang K; Liu X; Cai D; Fusco DN; Zhao L; Jeong SW; Brisac C; Chusri P; Schaefer EA; Zhao H; Peng LF; Lin W; Chung RT
    J Virol; 2015 Jul; 89(13):6608-18. PubMed ID: 25878102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.